Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATE trial of adjunctive intra-arterial tenecteplase after successful thrombectomy in anterior circulation large-vessel stroke
ChiCTR2400080624Phase 2Not yet recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tenecteplase in ischemic stroke (3 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoint: Proportion of patients with modified Rankin Scale 0 to 1 at 90 ± 14 days. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400080624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080624.